$GILD Recent Headlines Winning approval for new
Post# of 72749
Posted On: 03/06/2014 10:58:38 AM
$GILD Recent Headlines
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Yum Brands, Take-Two, CME are stocks to watch Tuesday 5:30 a.m. Feb. 4, 2014 - Sue Chang
More positive tests for hep C drug boost AbbVie and Enanta shares 10:52 a.m. Jan. 31, 2014 - blogs.marketwatch.com
Cash ain’t trash 1:55 p.m. Jan. 28, 2014 - The Trading Deck
Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape 9:46 a.m. Today - Zacks.com
Rigel Rises on Narrower Q4 Loss - Analyst Blog 9:40 a.m. Today - Zacks.com
Osiris Misses on Q4 Earnings - Analyst Blog 9:10 a.m. Today - Zacks.com
Bond Sales Spree Continues 8:12 p.m. March 5, 2014 - The Wall Street Journal Interactive Edition
The high cost of Gilead's Sovaldi giving Medicaid jaundice 12:33 p.m. March 5, 2014 - Seeking Alpha
Update on Alexion's Soliris - Analyst Blog 12:00 p.m. March 5, 2014 - Zacks.com
Dynavax Receives Milestone Payments from AstraZeneca - Analyst Blog 11:40 a.m. March 5, 2014 - Zacks.com
Pipeline Setback Overshadows XOMA's Q4 - Analyst Blog 10:52 a.m. March 5, 2014 - Zacks.com
Narrower-than-Expected Q4 Loss at GTx - Analyst Blog 9:50 a.m. March 5, 2014 - Zacks.com
Sunesis (SNSS) Jumps: Stock Moves 6.8% Higher - Tale of the Tape 9:25 a.m. March 5, 2014 - Zacks.com
Acorda Therapeutics (ACOR) Jumps: Stock Rises 7.5% - Tale of the Tape 9:18 a.m. March 5, 2014 - Zacks.com
Cramer's Mad Money - 5 Putin-Proof Sectors (3/4/14) 6:13 a.m. March 5, 2014 - Seeking Alpha
Bull of the Day: Quintiles (Q) - Bull of the Day 3:59 a.m. March 5, 2014 - Zacks.com
Jim Cramer's 'Mad Money' Recap: Stocks on Sale 8:08 p.m. March 4, 2014 - TheStreet.com
High-Grade Firms Dive Into Debt Market 5:48 p.m. March 4, 2014 - The Wall Street Journal Interactive Edition
AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog 5:10 p.m. March 4, 2014 - Zacks.com
Isis Pharma Slips on Wider-Than-Expected Q4 Loss - Analyst Blog 3:06 p.m. March 4, 2014 - Zacks.com
Theravance to Split in Q2 - Analyst Blog 12:00 p.m. March 4, 2014 - Zacks.com
Celldex Posts Narrower-Than-Expected Loss in Q4 - Analyst Blog 11:30 a.m. March 4, 2014 - Zacks.com
Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog 11:00 a.m. March 4, 2014 - Zacks.com
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. Today - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
Gilead Sciences to Release Fourth Quarter and Year End 2013 Financial Results on Tuesday, February 4, 2014 5:00 p.m. Jan. 28, 2014 - BusinessWire - BZX
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Yum Brands, Take-Two, CME are stocks to watch Tuesday 5:30 a.m. Feb. 4, 2014 - Sue Chang
More positive tests for hep C drug boost AbbVie and Enanta shares 10:52 a.m. Jan. 31, 2014 - blogs.marketwatch.com
Cash ain’t trash 1:55 p.m. Jan. 28, 2014 - The Trading Deck
Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape 9:46 a.m. Today - Zacks.com
Rigel Rises on Narrower Q4 Loss - Analyst Blog 9:40 a.m. Today - Zacks.com
Osiris Misses on Q4 Earnings - Analyst Blog 9:10 a.m. Today - Zacks.com
Bond Sales Spree Continues 8:12 p.m. March 5, 2014 - The Wall Street Journal Interactive Edition
The high cost of Gilead's Sovaldi giving Medicaid jaundice 12:33 p.m. March 5, 2014 - Seeking Alpha
Update on Alexion's Soliris - Analyst Blog 12:00 p.m. March 5, 2014 - Zacks.com
Dynavax Receives Milestone Payments from AstraZeneca - Analyst Blog 11:40 a.m. March 5, 2014 - Zacks.com
Pipeline Setback Overshadows XOMA's Q4 - Analyst Blog 10:52 a.m. March 5, 2014 - Zacks.com
Narrower-than-Expected Q4 Loss at GTx - Analyst Blog 9:50 a.m. March 5, 2014 - Zacks.com
Sunesis (SNSS) Jumps: Stock Moves 6.8% Higher - Tale of the Tape 9:25 a.m. March 5, 2014 - Zacks.com
Acorda Therapeutics (ACOR) Jumps: Stock Rises 7.5% - Tale of the Tape 9:18 a.m. March 5, 2014 - Zacks.com
Cramer's Mad Money - 5 Putin-Proof Sectors (3/4/14) 6:13 a.m. March 5, 2014 - Seeking Alpha
Bull of the Day: Quintiles (Q) - Bull of the Day 3:59 a.m. March 5, 2014 - Zacks.com
Jim Cramer's 'Mad Money' Recap: Stocks on Sale 8:08 p.m. March 4, 2014 - TheStreet.com
High-Grade Firms Dive Into Debt Market 5:48 p.m. March 4, 2014 - The Wall Street Journal Interactive Edition
AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog 5:10 p.m. March 4, 2014 - Zacks.com
Isis Pharma Slips on Wider-Than-Expected Q4 Loss - Analyst Blog 3:06 p.m. March 4, 2014 - Zacks.com
Theravance to Split in Q2 - Analyst Blog 12:00 p.m. March 4, 2014 - Zacks.com
Celldex Posts Narrower-Than-Expected Loss in Q4 - Analyst Blog 11:30 a.m. March 4, 2014 - Zacks.com
Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog 11:00 a.m. March 4, 2014 - Zacks.com
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. Today - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
Gilead Sciences to Release Fourth Quarter and Year End 2013 Financial Results on Tuesday, February 4, 2014 5:00 p.m. Jan. 28, 2014 - BusinessWire - BZX
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
(0)
(0)